These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30134546)

  • 1. Who's Driving? Human Cytomegalovirus, Interferon, and NFκB Signaling.
    Goodwin CM; Ciesla JH; Munger J
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30134546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U
    Goodwin CM; Schafer X; Munger J
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay between Human Cytomegalovirus and Pathogen Recognition Receptor Signaling.
    Marques M; Ferreira AR; Ribeiro D
    Viruses; 2018 Sep; 10(10):. PubMed ID: 30241345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.
    Amsler L; Verweij M; DeFilippis VR
    J Mol Biol; 2013 Dec; 425(24):4857-71. PubMed ID: 24013068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the innate immune response by human cytomegalovirus.
    Biolatti M; Gugliesi F; Dell'Oste V; Landolfo S
    Infect Genet Evol; 2018 Oct; 64():105-114. PubMed ID: 29935337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The battle between host antiviral innate immunity and immune evasion by cytomegalovirus.
    Li S; Xie Y; Yu C; Zheng C; Xu Z
    Cell Mol Life Sci; 2024 Aug; 81(1):341. PubMed ID: 39120730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus persistence.
    Goodrum F; Caviness K; Zagallo P
    Cell Microbiol; 2012 May; 14(5):644-55. PubMed ID: 22329758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus induces and exploits Roquin to counteract the IRF1-mediated antiviral state.
    Song J; Lee S; Cho DY; Lee S; Kim H; Yu N; Lee S; Ahn K
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18619-18628. PubMed ID: 31451648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response.
    Fu YZ; Guo Y; Zou HM; Su S; Wang SY; Yang Q; Luo MH; Wang YY
    PLoS Pathog; 2019 May; 15(5):e1007691. PubMed ID: 31107917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.
    El Baba R; Herbein G
    Front Immunol; 2021; 12():730765. PubMed ID: 34566995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface.
    Weisblum Y; Panet A; Zakay-Rones Z; Vitenshtein A; Haimov-Kochman R; Goldman-Wohl D; Oiknine-Djian E; Yamin R; Meir K; Amsalem H; Imbar T; Mandelboim O; Yagel S; Wolf DG
    Virology; 2015 Nov; 485():289-96. PubMed ID: 26318261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.
    Sabbaghian M; Gheitasi H; Fadaee M; Javadi Henafard H; Tavakoli A; Shekarchi AA; Poortahmasebi V
    Arch Virol; 2024 Jul; 169(8):157. PubMed ID: 38969819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction.
    Miller DM; Cebulla CM; Sedmak DD
    Curr Top Microbiol Immunol; 2002; 269():153-70. PubMed ID: 12224507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted evasion of the interferon response by cytomegalovirus.
    Marshall EE; Geballe AP
    J Interferon Cytokine Res; 2009 Sep; 29(9):609-19. PubMed ID: 19708810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response.
    Chen J; Xia S; Yang X; Chen H; Li F; Liu F; Chen Z
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29194430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.
    Gredmark-Russ S; Söderberg-Nauclér C
    Virulence; 2012 Nov; 3(7):621-34. PubMed ID: 23076329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus immune evasion of myeloid lineage cells.
    Brinkmann MM; Dağ F; Hengel H; Messerle M; Kalinke U; Čičin-Šain L
    Med Microbiol Immunol; 2015 Jun; 204(3):367-82. PubMed ID: 25776081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.